Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia (Q41217704)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8922564

retrieved

28 September 2017

review article

1 reference

stated in

Europe PubMed Central

title

Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8922564

retrieved

28 September 2017

main subject

pharmacology

1 reference

based on heuristic

inferred from title

Serenoa repens

object named as

Serenoa repens

1 reference

based on heuristic

inferred from title

author

Rex N. Brogden

series ordinal

2

object named as

R N Brogden

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8922564

retrieved

28 September 2017

author name string

G L Plosker

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8922564

retrieved

28 September 2017

publication date

1 November 1996

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8922564

retrieved

28 September 2017

published in

Drugs & Aging

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8922564

retrieved

28 September 2017

volume

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8922564

retrieved

28 September 2017

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8922564

retrieved

28 September 2017

page(s)

379-395

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8922564

retrieved

28 September 2017

cites work

Therapeutic controversies: clinical treatment of benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alternative therapy of benign prostatic hypertrophy--Permixon (Capistan)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate visualization studies in males homozygous and heterozygous for 5 alpha-reductase deficiency

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of finasteride (Proscar), a 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5 alpha reductase inhibition

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of androgen metabolism and binding by a liposterolic extract of "Serenoa repens B" in human foreskin fibroblasts

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and serenoa repens

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical localization of steroid 5 alpha-reductase 2 in the human male fetal reproductive tract and adult prostate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of finasteride (Proscar) and Serenoa repens (Permixon) in the inhibition of 5-alpha reductase in healthy male volunteers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression and regulation of steroid 5 alpha-reductase 2 in prostate disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the lipidic lipidosterolic extract of Serenoa repens (Permixon®) on the ionophore A23187-stimulated production of leukotriene B4 (LTB4) from human polymorphonuclear neutrophils

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Our experience with a hexane extract of Serenoa repens in the treatment of benign prostatic hypertrophy]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs. placebo]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5 alpha-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benign prostatic hyperplasia: diagnosis and treatment. Guideline overview. Agency for Health Care Policy and Research

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Anti-edematous action of a hexane extract of the stone fruit of Serenoa repens Bartr.]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The development of human benign prostatic hyperplasia with age

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Lipidosterolic Extract fromSerenoa repens Interferes with Prolactin Receptor Signal Transduction

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution study of radioactivity in rats after oral administration of the lipido/sterolic extract of Serenoa repens (Permixon) supplemented with [1-14C]-lauric acid, [1-14C]-oleic acid or [4-14C]-beta-sitosterol

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the lipidosterolic extract of Serenoa repens (Permixon) on human prostatic cell lines

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell type specific expression of steroid 5 alpha-reductase 2.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the metabolites formed in rat prostate following the in vivo administration of seven natural androgens

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Serenoa repens extract (Permixon) on estradiol/testosterone-induced experimental prostate enlargement in the rat

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binding of permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha 1-blockers vs 5 alpha-reductase inhibitors in benign prostatic hyperplasia. A comparative review

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sex-hormone-induced inflammation and fibromuscular proliferation in the rat lateral prostate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in the Metabolism of Dihydrotestosterone in the Hyperplastic Human Prostate*

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetic analysis of 5 alpha-reductase isoenzymes in benign prostatic hyperplasia (BPH)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

alpha-blockade in the treatment of symptomatic benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phytotherapeutic agents in the management of symptomatic benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Finasteride. A review of its potential in the treatment of benign prostatic hyperplasia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of the activity of 'basic' 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of permixon in benign prostatic hypertrophy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of benign prostatic hyperplasia. The Scandinavian BPH Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human prostatic steroid 5α-reductase isoforms—A comparative study of selective inhibitors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benign prostatic hyperplasia: pathophysiology and pharmacological treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benign prostatic hyperplasia. Medical and minimally invasive treatment options

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8922564

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00002512-199609050-00008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8922564

retrieved

28 September 2017

Dimensions Publication ID

1020360362

0 references

PubMed publication ID

8922564

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8922564

retrieved

28 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41217704&oldid=2204393888"